Soligenix
Developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Learn more
Launch date
Employees
Market cap
€7.1m
Enterprise valuation
€1m (Public information from Sep 2024)
Share price
$3.83 SNGX
Princeton New Jersey (HQ)
Authorizing premium user...